Omnadren

Omnadren is a combination testosterone injectable designed to blend fast- and slow-releasing esters so a single injection produces a quick onset with a long tail. The classic formulation paired testosterone propionate and phenylpropionate with two longer esters (historically caproate/isocaproate and, in older versions, hexahydrobenzylcarbonate variants); today's Omnadren 250 is compositionally equivalent to Sustanon 250 (propionate, phenylpropionate, isocaproate, decanoate).

Because every component is a testosterone ester, the pharmacology is testosterone pharmacology: the blend only shapes the release curve. Steady state builds over several injections as the long esters accumulate. It is well characterised as a testosterone product overall, so the research base is solid for the hormone, though the exact multi-ester kinetics are less rigorously published than single-ester preparations.

Each ester is hydrolysed at its own rate by serum esterases, releasing free testosterone that acts through the androgen receptor. Aromatisation to estradiol and 5-alpha reduction to DHT occur normally; the staggered esters produce an early peak followed by sustained levels.